A detailed history of Bank Of America Corp transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 273,469 shares of TMDX stock, worth $23.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
273,469
Previous 212,262 28.84%
Holding current value
$23.6 Million
Previous $15.7 Million 162.45%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$72.62 - $150.62 $4.44 Million - $9.22 Million
61,207 Added 28.84%
273,469 $41.2 Million
Q1 2024

May 15, 2024

BUY
$70.86 - $89.93 $3.33 Million - $4.23 Million
47,058 Added 28.48%
212,262 $15.7 Million
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $154,712 - $341,427
4,211 Added 2.62%
165,204 $13 Million
Q2 2023

Aug 14, 2023

SELL
$66.23 - $88.73 $1.86 Million - $2.5 Million
-28,156 Reduced 14.89%
160,993 $13.5 Million
Q1 2023

May 12, 2023

SELL
$53.63 - $82.33 $369,832 - $567,747
-6,896 Reduced 3.52%
189,149 $14.3 Million
Q4 2022

Feb 10, 2023

SELL
$39.08 - $64.29 $696,405 - $1.15 Million
-17,820 Reduced 8.33%
196,045 $12.1 Million
Q3 2022

Nov 14, 2022

BUY
$31.56 - $55.75 $496,501 - $877,059
15,732 Added 7.94%
213,865 $8.93 Million
Q2 2022

Aug 12, 2022

BUY
$20.56 - $32.15 $263,990 - $412,806
12,840 Added 6.93%
198,133 $6.23 Million
Q1 2022

May 16, 2022

BUY
$12.58 - $26.94 $305,505 - $654,237
24,285 Added 15.08%
185,293 $4.99 Million
Q4 2021

Feb 08, 2022

SELL
$19.16 - $32.68 $258,506 - $440,918
-13,492 Reduced 7.73%
161,008 $3.09 Million
Q3 2021

Nov 15, 2021

BUY
$25.92 - $34.51 $1.1 Million - $1.46 Million
42,292 Added 31.99%
174,500 $5.78 Million
Q2 2021

Sep 13, 2021

BUY
$21.63 - $40.07 $2.86 Million - $5.3 Million
132,208 New
132,208 $4.39 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.75B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.